<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04452916</url>
  </required_header>
  <id_info>
    <org_study_id>LEANER</org_study_id>
    <nct_id>NCT04452916</nct_id>
  </id_info>
  <brief_title>Physiological Response to 5 Days Fasting</brief_title>
  <official_title>Physiological Response to Prolonged Fasting in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate energy metabolism, anthropometry, blood pressure, gut microbiome, serum
      metabolome, glucose variability and neural mechanisms of food choice and mood before and
      after 5 days of fasting as well as their persistence in healthy men and women.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Waiting list control group</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resting Energy Expenditure</measure>
    <time_frame>6-th day of fasting compared to baseline</time_frame>
    <description>Measured by indirect calorimetry (kcal/d)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting Energy Expenditure - Recovery</measure>
    <time_frame>12 weeks after fasting compared to baseline</time_frame>
    <description>Measured by indirect calorimetry (kcal/d)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Respiratory Exchange Ratio</measure>
    <time_frame>6-th day of fasting and 28 days after fasting compared to baseline</time_frame>
    <description>Measured by indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Office systolic blood pressure</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Mean of five consecutive blood pressure measurements (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Office diastolic blood pressure</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Mean of five consecutive blood pressure measurements (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiome composition</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Measured by 16S Sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal and serum metabolome</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Measured by mass spectrometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in immune cell phenotypes</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Peripheral blood effector T cell frequencies (Percent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose variability</measure>
    <time_frame>From 3 days before until 6 days after fasting</time_frame>
    <description>Measured by continuous glucose monitoring over 14 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neural correlates of emotion processing</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Measured by functional Magnetic Resonance Imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neural correlates of food-specific delay discounting</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Measured by functional Magnetic Resonance Imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Stress Questionaire (PSQ)</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Range 0-100, with 0 indicating no perceived stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Self Efficiency</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Range 10-40, with 40 indicating highest self efficiency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PANAS Positive Affect Subscale (GESIS Panel)</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Range 10-50, with 50 indicating highest positive affect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PANAS Negative Affect Subscale (GESIS Panel)</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Range 10-50, with 50 indicating highest negative affect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Physical Activity Questionaire (IPAQ, long version)</measure>
    <time_frame>6-th day of fasting and 12 weeks after fasting compared to baseline</time_frame>
    <description>Time for moderate and vigorous activity (hours, minutes)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fasting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Starts immediately with 5 days of Buchinger fasting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting list control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Starts with 5 days of Buchinger fasting after a waiting period of 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Buchinger fasting</intervention_name>
    <description>Caloric intake of &lt; 250 kcal/d for 5 days</description>
    <arm_group_label>Fasting</arm_group_label>
    <arm_group_label>Waiting list control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women

          -  20-50 years

          -  Body mass index 20-30 kg/m2

        Exclusion Criteria:

          -  Clinically relevant heart, lung, liver, and kidney diseases

          -  Any prescribed medication (except for oral contraceptives)

          -  Current or chronic infection

          -  Intake of antibiotics within 6 months before study entry

          -  Fasting week within 6 months before study entry

          -  Habitual use of dietary supplements

          -  Food intolerances

          -  Pregnancy, lactation

          -  Vegan diet

          -  Smokers

          -  In addition for fMRI: sensorineural hearing loss, tinnitus, metal implants, electric
             devices
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anja Mähler, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anja Mähler, PhD</last_name>
    <phone>+4930450540323</phone>
    <email>anja.maehler@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Anja Mähler, PhD</last_name>
      <phone>+4930450540323</phone>
      <email>anja.maehler@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael Boschmann, MD</last_name>
      <phone>+4930450540241</phone>
      <email>michael.boschmann@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Weygandt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 23, 2020</study_first_submitted>
  <study_first_submitted_qc>June 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Anja Maehler</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results of reported articles (text, tables, figures, supplemental data) will be shared after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researchers who provide a methodologically sound proposal.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

